Ironwood Places $1B Bet on Biotech That Could Bring Its Next Blockbuster GI Drug
Ironwood Pharmaceuticals, a company whose drug research yielded a blockbuster gastrointestinal disorder drug, has struck a $1 billion deal to...
Ironwood Pharmaceuticals, a company whose drug research yielded a blockbuster gastrointestinal disorder drug, has struck a $1 billion deal to...
Over the pandemic, the amount of private equity investment in value-based care companies increased more than fourfold. This is encouraging,...
As artificial intelligence takes healthcare by storm, some physicians are expressing concern about being replaced by the technology. But would...
NeuroFlow — a Philadelphia-based startup that provides behavioral health integration software — struck a new health system partnership on Monday....
GLP-1 drugs like Ozempic and Wegovy, which help produce insulin in users’ bodies and make them feel fuller for longer,...
One top takeaway from a recent conference focused on the need for health systems—not just startups—to adopt an entrepreneurial mindset....
BY MICHAEL MILLENSON If you ask ChatGPT how many procedures a certain surgeon does or a specific hospital’s infection rate,...
Some stats from Citeline’s Pharma R&D Annual Report 2023. And by company sorted by pipeline size as of January 2023:...
A rare skin disorder that leads to fragile skin susceptible to frequent wounds and blisters now has its first FDA-approved...
Robotics startup Moon Surgical recently gained a healthy influx of capital and a distinguished board member. The company, based in...